Is Regenerative Medicine for Multiple Sclerosis A Hope or Hype?

What if treating multiple sclerosis meant looking beyond symptom management and exploring how the body’s own repair mechanisms could be supported?

Multiple sclerosis (MS), a chronic, immune-mediated condition that damages the myelin sheath protecting nerve fibres. The normal communication between the brain and other body parts gets disrupted. Symptoms such as fatigue, muscle weakness, vision problems and impaired coordination can affect everyday life, while disease progression varies considerably between individuals. Although existing treatments help manage disease activity, addressing inflammation and protecting vulnerable nerve cells remain important areas of research.

This is where regenerative medicine is attracting scientific interest. Mesenchymal stromal cells (MSCs) are being investigated for their immunomodulatory, anti-inflammatory and neuroprotective properties, with researchers exploring whether their biological signalling could help create a more supportive environment for nervous system function and repair.

The key question today involves: What does the current research infer about regenerative medicine? Can MSC-based approaches offer meaningful benefits for MS patients? What are the potential risks and underlying gaps? The current article explores the underlying scientific facts associated with Regenerative Medicines for Multiple Sclerosis. It unveils the underlying cellular mechanisms and potential in combating the symptoms. 

Ask The Expert

Why Is Regenerative Medicine Gaining Attention in Multiple Sclerosis?

The current conventional therapeutic regimen for MS primarily focuses on combating symptoms, reducing relapse and slowing disease progression. Although conventional therapeutics have promised efficient disease management, their ability to manage neurological damage remains limited. This has encouraged researchers and clinicians to explore regenerative approaches that can complement existing treatment. The core intent is to:     

• Moving beyond disease control, targeting restoration of lost or damaged nerve
• Exploring immune regulation, researchers are widely exploring mesenchymal stem cells (MSCs) that target multiple altered pathways
• Support neuroprotection via releasing neurotrophic factors
• Potential support for tissue repair by supporting myelin sheath repair
• Bridging the gap between MS management and recovery of the patient

*NOTE: Currently, researchers are widely exploring stem cells for multiple sclerosis as a regenerative approach. Though the study is at an early stage of development, the initial outcome appears promising.

Stem Cell for MS: How Does Science Work?

Stem cells for multiple sclerosis are a potential breakthrough that involves multiple mechanisms. The key targets involve:

Myelin Repair

• In MS, an individual’s immune cells attack the protective myelin coating around the nerve cells
• This disrupts the messaging/ signaling network
• Normally, the body has an excellent capacity for myelin sheath repair using oligodendrocyte precursor cells (OPCs)
• Multiple Sclerosis Stem Cell Treatment targets the cellular network for myelin sheath protection

Anti-Inflammation and Immunomodulation

• Researchers are incorporating MSCs that potentially release various anti-inflammatory molecules (IL-10)
• They potentially suppresses autoreactive immune cells (CD4+, CD8+, T cells, macrophages, B cells)
• They promote anti-inflammatory cytokine activities and calm the surrounding microenvironment

Paracrine Signaling

• MSCs migrate towards the injury site and potentially secrete various growth factors and cytokines
• They boost cell-to-cell communication and modulate multiple cellular networks
• They release various neurotrophic factors that create a neuroprotective environment [1,2]

MS Stem Cell Treatment: What Does Clinical Evidence Show?

Stem cell treatments for multiple sclerosis are at the initial stage of development. Preclinical and clinical studies have established positive trends. The key evidence includes:

• Early clinical studies have reported safety and tolerability of stem cell introduction among MS patients
• MSCs downregulated effect of pro-inflammatory cytokines (IFN-γ, IL-17, and IL-6), and upregulated anti-inflammatory cytokines (IL-10)
• MSCs and their secretome potentially protected against neuronal degeneration and supported remyelination [2]

*NOTE: Currently, both preclinical and early clinical studies are evolving. In future, the focus is on investigating comprehensive parameters and standardization of therapeutic procedures. Well-structured, large-scale clinical trials can potentially establish long-term efficacy and safety of the introduced Stem Cell for Multiple Sclerosis.   

MS Treatment in India: What Should Patients Know?

Multiple Sclerosis treatment in India follows the global treatment standards involving a combination of specialized medication, physical rehabilitation and relapse management. The key strategies involve:

• Medications: Oral medications (teriflunomide, dimethyl fumarate), injectables or infusion of monoclonal antibodies (natalizumab, ocrelizumab)
• Relapse Management: Oral corticosteroids or plasma exchange to manage severe relapse
• Rehabilitation: Involvement of the multidisciplinary team including physical therapy, occupational therapy, speech therapy, and neurologist aid in symptom management. It helps with comorbid condition management 
• Regenerative Medicine for Multiple Sclerosis: Currently, clinicians are introducing stem cell treatment for multiple sclerosis as a supportive option along with conventional treatment in specialized cases. The cost of stem cell therapy in India for multiple sclerosis​ ​ varies depending on various factors. This includes stem cell source, isolation procedure, quality, biological characterization, hospitalization cost, clinicians’ involvement and overall rehabilitation facilities. One must focus on the quality of the stem cells and treatment rather than considering the cost in the first place.

*NOTE: Patients and caregivers opting for multiple sclerosis stem cell treatment must consult experienced clinicians and renowned clinics. It is crucial to consider the stem cell type, source, isolation procedure, the individual’s overall health condition, and stem cell suitability for multiple sclerosis. Advancells, India, is a leading manufacturer and supplier of clinical-grade stem cells for various chronic conditions. The products come with a Certificate of Authentication (CoA).   

Hope or Hype? Making an Informed Treatment Decision

• Currently, Regenerative Medicine for Multiple Sclerosis offers scientific backing. Targeting multiple pathways like anti-inflammation, immunomodulation, stimulating repair signalling, and neuroprotection can potentially target the underlying cause
• The clinical evidence is still evolving. Future studies focus on launching well-established large-scale clinical trials
• Patients and family members must rely on evidence-based information before opting for any advanced therapeutics, including stem cells, for multiple sclerosis
• The cost of stem cell therapy in India for multiple sclerosis is based on stem cell quality, source, procedure, hospitalisation cost, clinical assessment, rehabilitation, and follow-up care

References

1. Smith JA, Nicaise AM, Ionescu RB, Hamel R, Peruzzotti-Jametti L, Pluchino S. Stem cell therapies for progressive multiple sclerosis. Frontiers in cell and developmental biology. 2021 Jul 9;9:696434. 
2. Wu L, Lu J, Lan T, Zhang D, Xu H, Kang Z, Peng F, Wang J. Stem cell therapies: a new era in the treatment of multiple sclerosis. Frontiers in neurology. 2024 May 9;15:1389697. 

FAQ’s

Q- Can stem cell treatment cure MS?

No, stem cell treatment is not a guaranteed cure for multiple sclerosis. Autologous haematopoietic stem cell transplantation (AHSCT) can help control disease activity in selected patients, while other approaches, including mesenchymal stromal cell research, are still being investigated.

Q- Is SCT for MS available in India?

Yes, stem cell treatment for multiple sclerosis is available at specialised centres as a supportive option and trail basis. Suitability depends on the type of MS, disease activity, previous treatments, and overall health. A neurologist should assess the potential benefits and risks before treatment.

Q- What is the cost of SCT in India for MS?

The cost of stem cell therapy in India for multiple sclerosis depends on the treatment approach, hospital facilities, pre-treatment assessments, hospitalisation, and follow-up care. Patients should request an itemised estimate from the treating centre and confirm what the quoted amount includes.

Q- Is stem cell treatment safe for people with MS?

Preclinical and early clinical evidence has supported safety of introducing stem cells among MS patients. It is crucial to undertake specialist consultation and approach renowned clinics to discuss and understand whether the potential benefits outweigh the risks.